Statistical Review: Data quality and clinical trial design
MicroBiome Restore is a general microbiome-support supplement and is not a GLP-1 medication, weight-loss product, or a substitute for prescribed treatment
Last reviewed: June 19, 2026 Last updated: June 19, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Intranasal retatrutide is an area of active research but is not established as an equivalent alternative to subcutaneous injection in terms of pharmacokinetics or efficacy
Effects on Weight Loss and Glycemic Control of Retatrutide, a Glucose-Dependent Insulinotropic Polypeptide, Glucagon-Like Peptide-1, and Glucagon Receptor Triagonist, in a Surrogate Model for Nonalcoholic Steatohepatitis in Mice